Document:

ex10-1.htm

    
      

    

    Exhibit
10.1

    

    FREEPORT-McMoRan
COPPER & GOLD INC.

    DIRECTOR
COMPENSATION

    (as
of May 2009)

    

    Cash
Compensation

    

    Each
non-management director of Freeport-McMoRan Copper & Gold Inc. receives an annual fee
of $70,000 for serving on the board.  Committee chairs receive an
additional annual fee as follows:  Audit Committee, $20,000; Corporate
Personnel Committee, $15,000; and all other committees, $10,000.  Each
committee member, excluding the chair of each committee, receives an additional
annual fee as follows:  Audit Committee members, $10,000; Corporate
Personnel Committee members, $7,500; and members of other committees,
$5,000.

    

    Each
non-management director also receives a fee of $1,500 for attending each board
meeting and each committee meeting (for which he or she is a member) and is
reimbursed for reasonable out-of-pocket expenses incurred in attending such
meetings.

    

    Equity-Based
Compensation; Deferrals

    

    The 2004
Director Compensation Plan, which was approved by the stockholders at the 2004
annual meeting, is an equity compensation plan for non-management
directors.  Pursuant to the plan, on June 1st of each
year, each non-management director receives a grant of options to acquire 10,000
shares of our common stock and 2,000 restricted stock units.  The
options are granted at fair market value on the grant date, vest ratably over
the first four anniversaries of the grant date and expire on the tenth
anniversary of the grant date.  The restricted stock units also vest
ratably over the first four anniversaries of the grant date.

    

    In
addition, the plan provides that participants may elect to exchange all or a
portion of their annual fee for an equivalent number of shares of our common
stock on the payment date, based on the fair market value of our common stock on
such date.  The plan further provides that participants may elect to
defer all or a portion of their annual fee and meeting fees, and that such
deferred amounts will accrue interest at a rate equal to the prime commercial
lending rate announced from time to time by JP Morgan Chase (compounded
quarterly), and shall be paid out at such time or times as directed by the
participant.

    

    Matching
Gifts Program

    

    Our
foundation administers a matching gifts program that is available to our
directors, officers, employees, full-time consultants and
retirees.  Under the program, the foundation will match a
participant’s gifts to eligible institutions, including educational
institutions, educational associations, educational funds, cultural
institutions, social service community organizations, hospital organizations and
environmental organizations.  The foundation provides the gifts
directly to the institution.  For directors, the foundation double
matches the first $1,000 of donations per year per eligible institution, and
single matches donations above $1,000.  The annual amount of our
matching gifts for any director may not exceed $40,000.

    

    Retirement
Plan for Non-Management Directors

    

    We have a
retirement plan for the benefit of our current non-management directors who
reach age 65.  In April 2008, the Board amended the plan to freeze the
maximum annual benefit at $40,000, except as provided below, and to terminate
the plan for future directors.  Thus, under the retirement plan, an
eligible director will be entitled to an annual benefit equal to a minimum of
$20,000 and a maximum of $40,000, depending on the number of years the retiree
served as a non-management director for us or our predecessors.  The
benefit is payable from the date of retirement until the retiree’s
death.  Each eligible director who was also a director of
Freeport-McMoRan Inc., our former parent, and who did not retire from that board
of directors, will receive upon retirement from our board an additional annual
benefit of $20,000, which is also payable from the date of retirement until the
retiree’s death.  This additional benefit is not subject to the
$40,000 maximum annual benefit described above.exh10-1.htm

     

      
        

      

    

    Exhibit
10.1

    

    EXECUTION
COPY

    

    AMENDMENT
TO AGREEMENT AND PLAN OF MERGER

    

    THIS
AMENDMENT (this “Amendment”) to the
Agreement and Plan of Merger, dated March 13, 2008, by and among Allion
Healthcare, Inc., Biomed Healthcare, Inc., Biomed America, Inc. and Parallex LLC
(the “Agreement”) is made
and entered into this 20th day of April, 2009, by and among Allion Healthcare,
Inc., a Delaware corporation (“Parent”), Biomed
Healthcare, Inc., a Delaware corporation and a wholly owned subsidiary of Parent
(“Merger Sub”),
Parallex LLC, a Delaware limited liability company (the “Owner”), Raymond A.
Mirra, Jr., in his capacity as the Stockholders’ Representative (the “Stockholders’
Representative”), and Raymond A. Mirra, Jr., in his capacity as an
individual (“Mirra”).

    

    W
I T N E S S E T H:

    

    WHEREAS,
as a condition and inducement to Parent’s and Merger Sub's willingness to enter
into this Amendment, each of Jennifer Hoefner and Peter Sartini have entered
into Restrictive Covenant Agreements, dated April 3, 2009, with Merger Sub and
certain other subsidiaries of Parent (copies of which are attached hereto as
Exhibit 1 through Exhibit 2); and

    

    WHEREAS,
Parent, Merger Sub and the Owner desire to clarify and amend certain provisions
of the Agreement, as hereinafter more particularly set forth, and the
Stockholders’ Representative and Mirra desire to acknowledge and agree to be
bound by such clarifications and amendments;

    

               NOW,
THEREFORE, for and in consideration of the premises, the mutual covenants
contained herein and other good and valuable consideration, the receipt,
adequacy and sufficiency of which are hereby acknowledged, Parent, Merger Sub,
the Owner, the Stockholders’ Representative and Mirra agree as
follows:

    

    AGREEMENT

    

    1. Escrow
Release.  Upon the execution of this Amendment by the Owner,
the Stockholders’ Representative and Mirra, and delivery of such executed
Amendment to Parent and Merger Sub, Parent and the Stockholders’ Representative
will execute a joint written instruction to the Escrow Agent (a copy of which is
attached hereto as Exhibit
3), advising the Escrow Agent to disburse the balance of the Escrow Funds
(as defined in the Escrow Agreement) to the Stockholders in accordance with the
Stockholder Allocation Schedule (as defined in the Escrow Agreement) as
currently in effect.  Parent and the Stockholders’ Representative
agree to deliver the joint written instruction to the Escrow Agent promptly
following its execution.

    

    2. Indemnification.  Notwithstanding
anything in the Agreement to the contrary, any payments required to be made
pursuant to Section 12.02 of the Agreement shall be made by the Owner in cash in
an amount equal to any Losses (subject to the limitations set forth in Sections
12.05(b) and 12.05(c) of the Agreement), of which the Owner may choose to pay up
to fifty-five percent (55%) in Parent Common Stock, with the monetary value of
such Parent Common Stock being determined based on the ten (10)-day average of
the closing price of Parent’s Common Stock at the time of payment of the
indemnity claim.

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    3. Mirra Indemnification
Agreement.  Mirra acknowledges and agrees that the revisions
set forth in this Amendment with respect to indemnification under the Agreement
shall also apply to Mirra’s indemnification obligations under the
Indemnification Agreement, dated March 13, 2008, by and among Parent, Merger Sub
and Mirra.

    

    MISCELLANEOUS

    

    1. Definitions.  All capitalized terms
used but not otherwise defined in this Amendment have the meanings ascribed to
them in the Agreement.

    

    2. Effect.  Except
as amended hereby, the Agreement shall remain in full force and effect. It is
agreed by the parties that all references to the Agreement hereafter made by
them in any document or instrument shall be deemed to refer to the Agreement as
amended hereby.

    

    3. Governing
Law.  This Amendment shall be governed by and construed and
enforced in accordance with the Laws of the State of Delaware, without regard to
any applicable conflicts of Laws.

    

    4.           Counterparts.  This
Amendment may be executed in any number of counterparts, all of which taken
together shall constitute one and the same instrument, and each of the parties
hereto may execute this Amendment by signing any of such counterparts. This
Amendment may also be executed and delivered by facsimile signature in two or
more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

    

    (Signatures
on Following Page)

    

    
      
        
           

        

         

      

      
         

        
          

        

      

      
         

      

    

    IN WITNESS WHEREOF, each of the
undersigned has caused this Amendment to be executed by an authorized officer as
of the date first above written.

    

    
      	
               
      

            	 

    

    
      	
              PARENT:

            	
              ALLION
      HEALTHCARE, INC.

            

    

    

    

    

    By:      /s/ Michael P.
Moran                                                                

    Name:  Michael P.
Moran                                                                         

                                    Title:  
Chief Executive
Officer and President

    

    

    

    
      	
              MERGER
      SUB:

            	
              BIOMED
      HEALTHCARE, INC.

            

    

    

    

    

    By:       /s/ Michael P.
Moran                                                                

    Name:  Michael P.
Moran                                                                               

                           
Title:   Chief Executive Officer and
President

    

    

    

    
      	
              OWNER:

            	
              PARALLEX
      LLC

            

    

    

    

    

    By:        /s/ Raymond A. Mirra,
Jr.                                                                

    Name :  Raymond A. Mirra,
Jr.

    Title:     President

    

    

    
      	
              STOCKHOLDERS’
      REPRESENTATIVE:

            	
              RAYMOND
      A. MIRRA, JR.

            

    

    

    

    

      /s/ Raymond A.
Mirra,
Jr.                                                                           

    

    

    

    
      	
              MIRRA:

            	
              RAYMOND
      A. MIRRA, JR.

            

    

    

    

    

       /s/
Raymond A. Mirra,
Jr.                                                                           

    

    

    

    (Signature
page to First Amendment to Agreement and Plan of
Merger)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]